# Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia

> **NCT05045443** · PHASE2 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 30 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia, Pediatric

## Interventions

- **DRUG:** Curcumin
- **DIETARY_SUPPLEMENT:** Standard of Care

## Key facts

- **NCT ID:** NCT05045443
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-22
- **Primary completion:** 2022-12-31
- **Final completion:** 2024-01-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05045443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05045443, "Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05045443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*